Arctoris has acquired the majority of Eli Lilly’s San Diego-based Lilly Life Sciences Studio’ laboratory, significantly expanding its research facilities and increasing the capacity to conduct multiple experiments simultaneously. This acquisition is expected to streamline R&D project timelines and address reproducibility and data ambiguity issues associated with traditional laboratory approaches.